SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 1

Evaluation of Low-Intensity Extracorporeal Shock Wave in the Treatment of Peyronie’s Disease: A Single Arm Observational Study

Turgay KARATAŞ
İbrahim Nüvit TAHTALI
Pages
31–35
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: While there was a statistically significant decrease (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The purpose of this study was to determine the efficacy of low-intensity extracorporeal wave therapy (Li- ESWT) in the treatment of Peyronie’s disease (PD).
📊
Key Findings & Data:Methods: Li-ESWT was used to treat 41 patients applied with PD using the Duolith SD1 Ultra device.
💡
Conclusion & Impact:Results: While there was a statistically significant decrease (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The purpose of this study was to determine the efficacy of low-intensity extracorporeal wave therapy (Li- ESWT) in the treatment of Peyronie’s disease (PD). Methods: Li-ESWT was used to treat 41 patients applied with PD using the Duolith SD1 Ultra device. In Peyronie’s patients, a total of 300 beats (3,000 strokes 0.25 mJ/mm2) were applied to the penile region to be Li-ESWT with clinical emphasis, that is, on the palpable Peyronie’s plaque, once a week for 6 weeks. The method’s reproducibility and efficacy were determined by comparing penile discomfort, penile curvature, penile plaque size, and International Index of Erectile Function (IIEF-5) score values in Peyronie’s patients at baseline and 3 months, 6 months, and 1 year after Li-ESWT treatment. Results: While there was a statistically significant decrease (p

🔖

Cite This Article

KARATAŞ, T., TAHTALI, İ. N. (2022). Evaluation of Low-Intensity Extracorporeal Shock Wave in the Treatment of Peyronie’s Disease: A Single Arm Observational Study. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 1, 31–35. https://ajindex.com/articles/535844

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ahmadnia H, Kamalati A, Younesi Rostami M, Imani MM, Asadpour AA, Hariri MK. The therapeutic effects of intracavernosal plaque excision in peyronie's disease: A none grafting or tunical excising procedure. World J Plast Surg 2016;5:62–6
  2. Salabas E, Ozmez A, Ermec B, Cevik G, Akdere H, Kadioglu A. Penile curvature after Peyronie's disease surgery: What are the risk factors? Andrologia 2020;52:e13860
  3. Krieger JR, Rizk PJ, Kohn TP, Pastuszak A. Shockwave therapy in the treatment of Peyronie's disease. Sex Med Rev 2019;7:499– 507
  4. Fojecki GL, Tiessen S, Osther PJ. Extracorporeal shock wave therapy (ESWT) in urology: A systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain. World J Urol 2017;35:1–9
  5. Brimley SC, Yafi FA, Greenberg J, Hellstrom WJG, Tue Nguyen HM, Hatzichristodoulou G. Review of management options for active-phase Peyronie's disease. Sex Med Rev 2019;7:329– 37
  6. Talib RA, Ibrahim MA, Cangüven Ö. Nonsurgical treatment options in Peyronie's disease: 2016 update. Turk J Urol 2016;42:217–23
  7. Russo GI, Milenkovic U, Hellstrom W, Levine LA, Ralph D, Albersen M. Clinical efficacy of ınjection and mechanical therapy for Peyronie's disease: A systematic review of the literature. Eur Urol 2018;74:767–81
  8. Porst H. Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 2021;9:93–122
  9. Neijenhuijs KI, Holtmaat K, Aaronson NK, Holzner B, Terwee CB, Cuijpers P, et al. The international index of erectile function (IIEF)-a systematic review of measurement properties. J Sex Med 2019;16:1078–91
  10. Gao L, Qian S, Tang Z, Li J, Yuan J. A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease. Int J Impot Res 2016;28:161–6. 11. d'Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: From mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg 2015;24:147–53
  11. Lin G, Reed-Maldonado AB, Wang B, Lee YC, Zhou J, Lu Z, et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med 2017;14:493– 501
  12. Walker DT, Amighi A, Mills SA, Eleswarapu SV, Mills JN. Managing the acute phase of Peyron